Skip to content

Arterial oxygenation targets in Intensive Care patients

ConservatIve versus Conventional Oxygenation in ICU patients - the ICONIC trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON19970
Enrollment
1512
Registered
2018-07-20
Start date
2018-11-19
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intensive Care patients Mechanical ventilation Oxygenation targets

Interventions

The conservative oxygenation arm will be targeted at PaO2 55-80 mmHg (7.3-10.7 kPa) and/or SpO2 91-94% and the conventional oxygenation arm will be targeted at PaO2 between 110-150 mmHg (14.7-20 kPa)

Sponsors

Leiden University Medical Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age ≥ 18 years Admission to an ICU participating in this study Need for intubation and mechanical ventilation An expected mechanical ventilation time of 24 hours or longer Inclusion within 2 hours after start of invasive ventilation in the study ICU or if previously intubated and ventilated within 2 hours after admission to the study ICU

Exclusion criteria

Exclusion criteria: Readmitted to the intensive care unit and prior ICONIC inclusion Invasive ventilation longer than 12 hours directly preceding admission Participation in other interventional trials which could influence ICONIC intervention and/or endpoints Suspected or confirmed pregnancy Decision to withhold life-sustaining treatment at the time of inclusion Acute respiratory distress syndrome (ARDS) with a PaO2/FiO2 ratio less than 150 mmHg Acute decompensation of chronic obstructive pulmonary disease(COPD) and/or chronic hypoxaemia and/or use of home oxygen therapy Underlying disease indication for hyperoxygenation (for example: carbon monoxide intoxication, decompression sickness, gas embolism) Severe anaemia (Hb< 4.0 mmol/l) that is not rapidly reversible (e.g. if blood transfusions are not possible or not allowed for religious reasons) Uncontrollable intracranial hypertension

Design outcomes

Primary

MeasureTime frame
All-cause mortality on day 28 after randomisation

Secondary

MeasureTime frame
The number of days alive and free from ventilation at day 28 after admission to the intensive care unit (ventilator-free days), ICU-mortality and in-hospital mortality ICU length of stay (LOS), hospital LOS Organ failure (daily) Reintubation rate Cost of hospitalization Ischemic events; myocardial, intestinal, cerebral or peripheral Delirium Blood stream infection and respiratory tract infection Surgical site infection Re-admission within 28 days Long term follow-up: Quality of life at 6 and 12 months after randomisation Patient opinion of research and consent in the emergency setting at 6 months after randomisation

Contacts

Public ContactC.C.A. Grim
c.c.a.grim@lumc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)